Piperazine → HCID 9971655, compound
Reaction equation
Cl[CH2:2][C:3]([NH:5][C:6]1[C:14]2[C:9](=[CH:10][C:11]([Cl:15])=[CH:12][CH:13]=2)[NH:8][N:7]=1)=[O:4].[NH:16]1[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]1>C(#N)C>[Cl:15][C:11]1[CH:10]=[C:9]2[C:14]([C:6]([NH:5][C:3](=[O:4])[CH2:2][N:16]3[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]3)=[N:7][NH:8]2)=[CH:13][CH:12]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
The process is performed as in Example 75, starting with 500 mg of 2-chloro-N-(6-chloro-1H-indazol-3-yl)acetamide, 15 cm3 of acetonitrile and 528 mg of piperazine. The reaction medium is refluxed for 1 hour and then concentrated to dryness under reduced pressure (2 kPa; 50° C.); the crude product is purified by chromatography under an argon pressure of 50 kPa, on a column of silica gel (particle size 40-60 μm; diameter 2.5 cm), eluting with a methylene chloride/methanol/aqueous ammonia mixture (90/10/1 by volume). The fractions containing the expected product are combined, concentrated under reduced pressure and then dried (90 Pa; 45° C.) to give 380 mg of N-(6-chloro-1H-indazol-3-yl)-1-piperazineacetamide in the form of a white foam.
Workup
- temperatureThe reaction medium is refluxed for 1 hour
- concentrationconcentrated to dryness under reduced pressure (2 kPa; 50° C.)
- customthe crude product is purified by chromatography under an argon pressure of 50 kPa
- washon a column of silica gel (particle size 40-60 μm; diameter 2.5 cm), eluting with a methylene chloride/methanol/aqueous ammonia mixture (90/10/1 by volume)
- additionThe fractions containing the expected product
- concentrationconcentrated under reduced pressure
- customdried (90 Pa; 45° C.)
Sources & evidence
- ORD record
- ord-12c80e95dee84e2d9812cfa246ee9f82
- Source dataset
- uspto-grants-2005_09
- Patent number
- US06949579B2
Reaction notes
Loading…